Published on:

Recall of Lo/Ovral-28 and Norgestrel/Ethinyl Estradiol Tablets

Pfizer Inc. has recalled 14 lots of Lo/Ovral-28 (norgestrel and Ethinyl estradiol) Tablets and 14 lots of Norgestrel and Ethinyl Estradiol Tablets (generic), as an investigation found that some blister packs may contain an inexact count of inert or active ingredient tablets and that the tablets may be out of sequence.

These products are oral contraceptives indicated for the prevention of pregnancy. These tablets were manufactured and packaged by Pfizer Inc. and labeled under the Akrimax Pharmaceuticals brand.

As a result of this packaging error, the daily regimen for these oral contraceptives may be incorrect and could leave women without adequate contraception, and at risk for unintended pregnancy. These packaging defects do not pose any immediate health risks. However, consumers exposed to affected packaging should begin using a non-hormonal form of contraception immediately. Patients who have the affected product should notify their physician and return the product to the pharmacy.

These products are packaged in blister packs containing 21 tablets of active ingredients and seven tablets of inert ingredients. Correct dosing of this product is important in avoiding the associated risks of an unplanned pregnancy.

There will be lawsuits here, but I don’t know what to make of them. Surely, there are potential wrongful birth suits. But the damages are the difference between the cost of having a child you did not want and the joy you get from that child. If you argue in court that your healthy child is more of a burden than the cost warrants… well, you are not a very nice person.